Study of Anti-Epidermal Growth Factor Receptor (EGFr) Antibody, Cetuximab, in Combination With Gemcitabine/Carboplatin in Patients With Stage IV Lung Cancer

This study has been completed.

Study NCT01004731 Information provided by University of Alabama at Birmingham

First Received: October 21, 2009 Last Updated: December 4, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	January 2006
Primary Completion Date:	January 2002 (Final data collection date for primary outcome measure)